EIM
AXDX

Essex Investment Management’s Accelerate Diagnostics AXDX Stock Holding History

Essex Investment Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,935
Closed -$1.66M – 478
2019
Q3 		$1.66M Buy
8,935
+2,210
+33% +$427K 0.24% 135
2019
Q2 		$1.54M Buy
+6,725
New +$1.32M 0.21% 160
2017
Q4 		– Sell
-6,874
Closed -$1.54M – 363
2017
Q3 		$1.54M Sell
6,874
-902
-12% -$222K 0.21% 164
2017
Q2 		$2.13M Buy
+7,776
New +$2.11M 0.3% 108

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Essex Investment Management's AXDX Position: Q4 2019 in Review

Essex Investment Management sold out of Accelerate Diagnostics (AXDX) in Q4 2019, closing a stake of 8,935 shares — an estimated $1.66M sold.

Essex Investment Management first reported a position in AXDX in Q2 2017 and held it in 4 quarters. The position peaked at $2.13M in Q2 2017. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2019.

  • Essex Investment Management reported no remaining Accelerate Diagnostics position as of Q4 2019 after selling out during the quarter.
  • Essex Investment Management sold 8,935 Accelerate Diagnostics shares in Q4 2019, an estimated $1.66M.
  • Essex Investment Management first reported a position in Accelerate Diagnostics in Q2 2017 and held it in 4 quarters.
  • Essex Investment Management's Accelerate Diagnostics position peaked at $2.13M in Q2 2017.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2019.

Based on Essex Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.